PubMed Health⌕ Search

PubMed · 11070525

Limitations in using existing alcohol treatment trials to develop practice guidelines.

Abstract

In recent years, substantial efforts have been made to identify "best practices" and develop comprehensive practice guidelines for the treatment of various psychiatric disorders and medical conditions, based on systematic, often quantitative reviews of the existing intervention research. There probably are more than 300 comparative treatment trials that have been conducted in the alcohol field. With this large body of research, one might think the development of alcohol treatment guidelines would be a straightforward task. Unfortunately, that is not the case. Four problems are discussed with the "box-score" reviews that have been conducted thus far to identify effective alcohol treatment modalities. At least two of these problems are fundamental barriers to determining the relative efficacy or effectiveness of alcohol treatment modalities even in "meta-analyses" with "effect sizes". These impediments are discussed, as is how future alcohol treatment trials could be conducted so that their findings would more readily inform practice guidelines.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J W Finney. 2000. Limitations in using existing alcohol treatment trials to develop practice guidelines.. https://doi.org/10.1046/j.1360-0443.2000.951014914.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Alcohol-related disorders: etiopathology and therapeutic considerations].

The scientific understanding of the neurobiological priniciples of alcoholism has made significant progress in recent years. Especially the effects of ethanol on the neurotransmitter-systems are well studied. Dopaminergic and GABAergic facilitation contribute to the stimulating effects of low doses of alcohol while many of its adverse effects are mediated by glutamatergic inhibition at higher doses. A reduced serotonine-metabolism was shown to be a risk factor for the development of an alcohol dependence. The historic success of absinthe is discussed in this context. Absinthe is a mixture of ethanol and thujone, a substance that leads to a GABAergic inhibition as well as a reduced serotonergic responsiveness. Many studies substantiate the role of cannabinoid as well as striatal opiate-receptors in alcohol-related disorders. Neuroimaging studies could prove the important role of the reward system in this connection. Genetic factors were shown to be predisposing, however biological and environmental factors have a regulatory effect on the gene expression. Disturbances of the hpa-axis (hypothalamus-pituitary gland-adrenal cortex) were also shown to play a role in alcohol dependence. The understanding of these neurobiological principles of alcohol-related disorders should contribute to enhance and improve their therapeutic options.

Alcohol-Related Disorders↗

[Palinacousis in alcohol hallucinosis].

OBJECTIVE: Palinacousis seems to be a rare phenomenon in mental disorders. METHODS: In this paper, we report on a subject with alcohol hallucinosis who displayed one episode with palinacousis after remission from the typical acoustic hallucinations according to the disorder. DISCUSSION: The theoretical background and the relevance of this observation are discussed.

Alcohol-Related Disorders↗